Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Cervical Cancer

Free Subscription Articles published in Radiother Oncol Retrieve available abstracts of 49 articles: HTML format Text format

Single Articles

June 2018
1. JENSEN NBK, Potter R, Kirchheiner K, Fokdal L, et al
   Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study.
   Radiother Oncol. 2018 Jun 4. pii: S0167-8140(18)30275.
   PubMed     Text format     Abstract available
   
   
   May 2018
2. LEE J, Wu MH, Chen YJ
   Delineation guideline for the para-aortic lymph node region in cervical cancer.
   Radiother Oncol. 2018 May 26. pii: S0167-8140(18)30251.
   PubMed     Text format    
   
   
   
3. FOKDAL L, Potter R, Kirchheiner K, Lindegaard JC, et al
   Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer.
   Radiother Oncol. 2018 May 18. pii: S0167-8140(18)30242.
   PubMed     Text format     Abstract available
   
   
   April 2018
4. CIBULA D, Potter R, Planchamp F, Avall-Lundqvist E, et al
   The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer.
   Radiother Oncol. 2018 Apr 12. pii: S0167-8140(18)30135.
   PubMed     Text format     Abstract available
   
   
   
5. NAJJARI JAMAL D, Potter R, Haie-Meder C, Lindegaard JC, et al
   Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study.
   Radiother Oncol. 2018 Apr 6. pii: S0167-8140(18)30170.
   PubMed     Text format     Abstract available
   
   
   
6. SMET S, Potter R, Haie-Meder C, Lindegaard JC, et al
   Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study.
   Radiother Oncol. 2018 Apr 4. pii: S0167-8140(18)30141.
   PubMed     Text format     Abstract available
   
   
   March 2018
7. KEENAN LG, Rock K, Azmi A, Salib O, et al
   An atlas to aid delineation of para-aortic lymph node region in cervical cancer: Design and validation of contouring guidelines.
   Radiother Oncol. 2018 Mar 6. pii: S0167-8140(18)30084.
   PubMed     Text format     Abstract available
   
   
   February 2018
8. GERBER R, Rink A, Croke J, Borg J, et al
   Comparison of dosimetric parameters derived from whole organ and wall contours for bladder and rectum in cervical cancer patients treated with intracavitary and interstitial brachytherapy.
   Radiother Oncol. 2018 Feb 6. pii: S0167-8140(18)30041.
   PubMed     Text format     Abstract available
   
   
   November 2017
9. SMOLIC M, Sombroek C, Bloemers MCWM, van Triest B, et al
   Needle use and dosimetric evaluation in cervical cancer brachytherapy using the Utrecht applicator.
   Radiother Oncol. 2017 Nov 29. pii: S0167-8140(17)32723.
   PubMed     Text format     Abstract available
   
   
   September 2017
10. NOVAKOVA E, Heijkoop ST, Quint S, Zolnay AG, et al
    What is the optimal number of library plans in ART for locally advanced cervical cancer?
    Radiother Oncol. 2017 Sep 19. pii: S0167-8140(17)32557.
    PubMed     Text format     Abstract available
    
    
    May 2017
11. DEL CAMPO ER, Rivera S, Martinez-Paredes M, Hupe P, et al
    Assessment of the novel online delineation workshop dummy run approach using FALCON within a European multicentre trial in cervical cancer (RAIDs).
    Radiother Oncol. 2017 May 19. pii: S0167-8140(17)30372.
    PubMed     Text format     Abstract available
    
    
    
12. LI N, Noticewala SS, Williamson CW, Shen H, et al
    Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer.
    Radiother Oncol. 2017;123:325-330.
    PubMed     Text format     Abstract available
    
    
    April 2017
13. DE BOER P, Jurgenliemk-Schulz IM, Westerveld H, de Leeuw AAC, et al
    Patterns of care survey: Radiotherapy for women with locally advanced cervical cancer.
    Radiother Oncol. 2017 Apr 20. pii: S0167-8140(17)30145.
    PubMed     Text format     Abstract available
    
    
    
14. ANDREYCHENKO A, Kroon PS, Maspero M, Jurgenliemk-Schulz I, et al
    The feasibility of semi-automatically generated red bone marrow segmentations based on MR-only for patients with gynecologic cancer.
    Radiother Oncol. 2017;123:164-168.
    PubMed     Text format     Abstract available
    
    
    March 2017
15. VAN HEERDEN LE, Houweling AC, Koedooder K, van Kesteren Z, et al
    Structure-based deformable image registration: Added value for dose accumulation of external beam radiotherapy and brachytherapy in cervical cancer.
    Radiother Oncol. 2017 Mar 31. pii: S0167-8140(17)30111.
    PubMed     Text format     Abstract available
    
    
    
16. MENDEZ LC, Weiss Y, D'Souza D, Ravi A, et al
    Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: A systematic review of technique, local control and toxicities.
    Radiother Oncol. 2017 Mar 25. pii: S0167-8140(17)30101.
    PubMed     Text format     Abstract available
    
    
    February 2017
17. YAMAZAKI H, Nakamura S, Suzuki G, Yoshida K, et al
    Comment on "Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer" Kari Tanderup et al.
    Radiother Oncol. 2017 Feb 22. pii: S0167-8140(17)30067.
    PubMed     Text format    
    
    
    
18. RAMLOV A, Assenholt MS, Jensen MF, Gronborg C, et al
    Clinical implementation of coverage probability planning for nodal boosting in locally advanced cervical cancer.
    Radiother Oncol. 2017 Feb 9. pii: S0167-8140(17)30040.
    PubMed     Text format     Abstract available
    
    
    January 2017
19. SHACK L, Lu S, Weeks LA, Craighead P, et al
    Determining the need and utilization of radiotherapy in cancers of the breast, cervix, lung, prostate and rectum: A population level study.
    Radiother Oncol. 2017;122:152-158.
    PubMed     Text format     Abstract available
    
    
    November 2016
20. EMINOWICZ G, Rompokos V, Stacey C, Hall L, et al
    Understanding the impact of pelvic organ motion on dose delivered to target volumes during IMRT for cervical cancer.
    Radiother Oncol. 2016 Nov 16. pii: S0167-8140(16)34365.
    PubMed     Text format     Abstract available
    
    
    August 2016
21. LESEUR J, Roman-Jimenez G, Devillers A, Ospina-Arango JD, et al
    Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer.
    Radiother Oncol. 2016 Aug 25. pii: S0167-8140(16)31249.
    PubMed     Text format     Abstract available
    
    
    
22. HAN K, Croke J, Foltz W, Metser U, et al
    A prospective study of DWI, DCE-MRI and FDG PET imaging for target delineation in brachytherapy for cervical cancer.
    Radiother Oncol. 2016 Aug 12. pii: S0167-8140(16)31234.
    PubMed     Text format     Abstract available
    
    
    
23. MAZERON R, Gouy S, Chargari C, Rivin Del Campo E, et al
    Post radiation hysterectomy in locally advanced cervical cancer: Outcomes and dosimetric impact.
    Radiother Oncol. 2016 Aug 2. pii: S0167-8140(16)31202.
    PubMed     Text format     Abstract available
    
    
    July 2016
24. JASTANIYAH N, Yoshida K, Tanderup K, Lindegaard JC, et al
    A volumetric analysis of GTVD and CTVHR as defined by the GEC ESTRO recommendations in FIGO stage IIB and IIIB cervical cancer patients treated with IGABT in a prospective multicentric trial (EMBRACE).
    Radiother Oncol. 2016 Jul 21. pii: S0167-8140(16)31158.
    PubMed     Text format     Abstract available
    
    
    
25. SOLIMAN AS, Elzibak A, Easton H, Kim JY, et al
    Quantitative MRI assessment of a novel direction modulated brachytherapy tandem applicator for cervical cancer at 1.5T.
    Radiother Oncol. 2016 Jul 18. pii: S0167-8140(16)31198.
    PubMed     Text format     Abstract available
    
    
    
26. MAZERON R, Fokdal LU, Kirchheiner K, Georg P, et al
    Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study.
    Radiother Oncol. 2016 Jul 7. pii: S0167-8140(16)31154.
    PubMed     Text format     Abstract available
    
    
    June 2016
27. TANDERUP K, Fokdal LU, Sturdza A, Haie-Meder C, et al
    Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
    Radiother Oncol. 2016 Jun 24. pii: S0167-8140(16)31117.
    PubMed     Text format     Abstract available
    
    
    
28. MOHAMED S, Lindegaard JC, de Leeuw AA, Jurgenliemk-Schulz I, et al
    Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer.
    Radiother Oncol. 2016 Jun 3. pii: S0167-8140(16)31123.
    PubMed     Text format     Abstract available
    
    
    May 2016
29. WESTERVELD H, de Leeuw A, Kirchheiner K, Dankulchai P, et al
    Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients.
    Radiother Oncol. 2016 May 26. pii: S0167-8140(16)31090.
    PubMed     Text format     Abstract available
    
    
    
30. EMINOWICZ G, Rompokos V, Stacey C, McCormack M, et al
    The dosimetric impact of target volume delineation variation for cervical cancer radiotherapy.
    Radiother Oncol. 2016 May 6. pii: S0167-8140(16)31074.
    PubMed     Text format     Abstract available
    
    
    
31. RIBEIRO I, Janssen H, De Brabandere M, Nulens A, et al
    Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Radiother Oncol. 2016 May 2. pii: S0167-8140(16)31050.
    PubMed     Text format     Abstract available
    
    
    April 2016
32. STURDZA A, Potter R, Fokdal LU, Haie-Meder C, et al
    Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.
    Radiother Oncol. 2016 Apr 29. pii: S0167-8140(16)31018.
    PubMed     Text format     Abstract available
    
    
    
33. FOKDAL L, Sturdza A, Mazeron R, Haie-Meder C, et al
    Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study.
    Radiother Oncol. 2016 Apr 21. pii: S0167-8140(16)31027.
    PubMed     Text format     Abstract available
    
    
    February 2016
34. LUTGENS LC, Koper PC, Jobsen JJ, van der Steen-Banasik EM, et al
    Radiation therapy combined with hyperthermia versus cisplatin for locally advanced cervical cancer: Results of the randomized RADCHOC trial.
    Radiother Oncol. 2016 Feb 17. pii: S0167-8140(16)00068.
    PubMed     Text format     Abstract available
    
    
    
35. PARK JJ, Kim CK, Park BK
    Prognostic value of diffusion-weighted magnetic resonance imaging and F-fluorodeoxyglucose-positron emission tomography/computed tomography after concurrent chemoradiotherapy in uterine cervical cancer.
    Radiother Oncol. 2016 Feb 15. pii: S0167-8140(16)00072.
    PubMed     Text format     Abstract available
    
    
    January 2016
36. KIRCHHEINER K, Nout RA, Lindegaard JC, Haie-Meder C, et al
    Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.
    Radiother Oncol. 2016 Jan 9. pii: S0167-8140(16)00002.
    PubMed     Text format     Abstract available
    
    
    
37. WYSS JC, Carmona R, Karunamuni RA, Pritz J, et al
    [(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients.
    Radiother Oncol. 2016;118:72-8.
    PubMed     Text format     Abstract available
    
    
    December 2015
38. LINDEGAARD JC, Madsen ML, Traberg A, Meisner B, et al
    Individualised 3D printed vaginal template for MRI guided brachytherapy in locally advanced cervical cancer.
    Radiother Oncol. 2015 Dec 29. pii: S0167-8140(15)00672.
    PubMed     Text format     Abstract available
    
    
    September 2015
39. HEIJKOOP ST, Langerak TR, Quint S, Mens JW, et al
    Quantification of intra-fraction changes during radiotherapy of cervical cancer assessed with pre- and post-fraction Cone Beam CT scans.
    Radiother Oncol. 2015 Sep 22. pii: S0167-8140(15)00476.
    PubMed     Text format     Abstract available
    
    
    
40. GLADWISH AP, Han K, Foltz WD
    Variation in apparent diffusion coefficient measurements among women with locally advanced cervical cancer.
    Radiother Oncol. 2015 Sep 13. pii: S0167-8140(15)00468.
    PubMed     Text format     Abstract available
    
    
    August 2015
41. KIRISITS C, Federico M, Nkiwane K, Fidarova E, et al
    Quality assurance in MR image guided adaptive brachytherapy for cervical cancer: Final results of the EMBRACE study dummy run.
    Radiother Oncol. 2015 Aug 24. pii: S0167-8140(15)00407.
    PubMed     Text format     Abstract available
    
    
    
42. KOBAYASHI K, Murakami N, Wakita A, Nakamura S, et al
    Dosimetric variations due to interfraction organ deformation in cervical cancer brachytherapy.
    Radiother Oncol. 2015 Aug 24. pii: S0167-8140(15)00442.
    PubMed     Text format     Abstract available
    
    
    
43. CHAI Y, Wang J, Wang T, Yang Y, et al
    Application of H NMR spectroscopy-based metabonomics to feces of cervical cancer patients with radiation-induced acute intestinal symptoms.
    Radiother Oncol. 2015 Aug 12. pii: S0167-8140(15)00397.
    PubMed     Text format     Abstract available
    
    
    July 2015
44. MAZERON R, Maroun P, Castelnau-Marchand P, Dumas I, et al
    Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: Dose-volume effect relationships for the rectum and bladder.
    Radiother Oncol. 2015 Jul 8. pii: S0167-8140(15)00324.
    PubMed     Text format     Abstract available
    
    
    May 2015
45. LUND KV, Simonsen TG, Hompland T, Kristensen GB, et al
    Short-term pretreatment DCE-MRI in prediction of outcome in locally advanced cervical cancer.
    Radiother Oncol. 2015 May 18. pii: S0167-8140(15)00210.
    PubMed     Text format     Abstract available
    
    
    
46. DINGES E, Felderman N, McGuire S, Gross B, et al
    Bone marrow sparing in intensity modulated proton therapy for cervical cancer: Efficacy and robustness under range and setup uncertainties.
    Radiother Oncol. 2015 May 13. pii: S0167-8140(15)00214.
    PubMed     Text format     Abstract available
    
    
    
47. TEO BK, Bonner Millar LP, Ding X, Lin LL, et al
    Assessment of cumulative external beam and intracavitary brachytherapy organ doses in gynecologic cancers using deformable dose summation.
    Radiother Oncol. 2015;115:195-202.
    PubMed     Text format     Abstract available
    
    
    February 2015
48. PALMER AL, Diez P, Gandon L, Wynn-Jones A, et al
    A multicentre 'end to end' dosimetry audit for cervix HDR brachytherapy treatment.
    Radiother Oncol. 2015;114:264-71.
    PubMed     Text format     Abstract available
    
    
    December 2014
49. ARNESEN MR, Bruheim K, Malinen E, Hellebust TP, et al
    Spatial dosimetric sensitivity of contouring uncertainties in gynecological 3D-based brachytherapy.
    Radiother Oncol. 2014;113:414-9.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: